全球表皮微流體診斷技術的進步和成長機會

Global Epifluidic Diagnostics Technology Advancements and Growth Opportunities

出版日期: 2023年07月26日 | 出版商:

Frost & Sullivan | 英文 58 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

靈活的微流體和電子顛覆性技術推動下一代設備的開發

這項研究服務探索表皮微流體診斷技術的進步，並揭示其帶給醫療保健行業的成長機會。表皮微流體診斷是一種新型穿戴式診斷技術，可透過緊貼皮膚的微流體系統分析汗液和間質液 (ISF)。配備微電子、感測器和軟性微流體，穿戴在皮膚上的軟性微型設備可以長時間連續、無痛地採樣替代生物流體，以進行精確的健康監測，可以對診斷對象進行連續即時監測。該領域的技術進步，特別是人工智慧（AI）和機器學習（ML）解決方案的整合，將有助於提高診斷準確性並提高用戶便利性。

研究人員發現，基於汗液和 ISF 的診斷可用於多種用途，包括病毒感染檢測、囊性纖維化診斷、尿素監測和帕金森氏症管理。基於汗液的表皮微流診斷技術主要用於供給管理和物質使用檢測，而基於ISF的表皮微流診斷技術用於代謝物檢測。主要企業積極擴展基於 ISF 的表皮微流體診斷，以實現更多臨床用途，例如治療藥物監測、心血管疾病監測和膿毒症檢測。影響多個領域的表皮微流體診斷在未來幾年具有巨大的市場潛力。

本報告全面涵蓋了不同類型的表皮微流體診斷技術及其優勢，以確定驅動和限制該市場成長的因素。它還確定了基於汗液的表皮微流體診斷和基於 ISF 的表皮微流體診斷的關鍵參與企業，並檢驗了它們的技術採用、目標用途和商業性完備等級。本研究還涵蓋了資金籌措、併購和專利申請等區域和行業趨勢。基準年為2022年，預測期為2023-2027年。

針對不同目標分析物的汗液和基於 ISF 的表皮微流體診斷的商業性可用性
表皮微流控診斷：多樣化的應用和發展現狀
表皮微流控診斷技術路線圖
表皮微流控診斷裝置發展的區域趨勢
表皮微流控診斷器械行業併購分析（2020-2023年）
表皮微流診斷政府資助分析（2020-2023）
表皮微流體診斷私人資金籌措概況，2020-2023年

專利分析

表皮微流控診斷知識產權活動分析（2018-2023）
基於汗液的表皮微流控診斷技術 - 創新主題分析（2018-2023）
基於ISF的表皮微流控診斷技術 - 創新主題分析（2018-2023）

成長機會宇宙

成長機會1：利用替代樣品分析生物流體的新型微流體系統
成長機會2：物聯網、AI/ML算法等先進資訊通訊技術
成長機會3：主要參與者、學術機構和政府之間的合作

附錄

技術完備等級 (TRL)：解釋
專利

下一步

下一步
為什麼選擇Frost，為什麼是現在？
免責聲明

簡介目錄

Product Code: DAB3

Disruptive technologies in flexible microfluidics and electronics are driving the development of next-generation devices

This research service examines the advancements in epifluidic diagnostics technology, identifying the growth opportunities they present for the healthcare industry. Epifluidic diagnostics is an emerging class of wearable diagnostics that enables sweat and interstitial fluid (ISF) analysis through skin-interfaced microfluidic systems. These body-worn skin-conformable and flexible miniature devices with microelectronics, sensors, and flexible microfluidics allow long-term, painless, and continuous sampling of the alternate biofluids and real-time and continuous monitoring of diagnostic targets for precise health management. Technology advancements in this field, particularly the integration of artificial intelligence (AI) and machine learning (ML) solutions, help enable higher diagnostics accuracy and enhanced user convenience.

Researchers have found evidence that sweat- and ISF-based diagnostics can be used for a diverse range of applications, including viral infection detection, cystic fibrosis diagnosis, urea monitoring, and Parkinson's disease management. Sweat-based epifluidic diagnostics are predominantly utilized for hydration management and substance-use detection, while ISF-based epifluidic diagnostics are employed for metabolite measurement. Key players are actively expanding ISF-based epifluidic diagnostics for more clinical uses, such as therapeutic drug monitoring, cardiovascular disease monitoring, and sepsis detection. With several sectors of impact, epifluidic diagnostics has high market potential in the coming years.

The report takes a comprehensive look at the different types of epifluidic diagnostic technologies and their benefits and identifies the factors driving and restraining the growth of this market. It also identifies the key participants in the sweat-based epifluidic diagnostics and ISF-based epifluidic diagnostics segments, examining the technologies they employ, their target applications, and commercial readiness levels. The study covers regional and industry trends, including funding rounds, mergers and acquisitions (M&A), and patents filed. The base year is 2022, and the forecast period is 2023 to 2027.

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Epifluidic Diagnostics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Growth Opportunity Analysis

Conventional Diagnostics and Epifluidic Diagnostics: A Comparison
Components of an Epifluidic Diagnostic Device and Emerging Innovations
Segmentation
Growth Drivers
Growth Restraints
Scope of Analysis

Technology Analysis: Sweat-based Epifluidic Diagnostics

Overview
Competitive Environment
Emerging Sweat-sensing Applications from the Academic Innovation Ecosystem

Technology Analysis: ISF-based Epifluidic Diagnostics

Overview
Competitive Environment
Emerging ISF-sensing Applications from the Academic Innovation Ecosystem

Innovation Indicators

Commercial Availability of Sweat- and ISF-based Epifluidic Diagnostics for Different Target Analytes
Epifluidic Diagnostics: Diverse Applications and Development Status
Technology Roadmap of Epifluidic Diagnostics
Regional Trends of Epifluidic Diagnostic Device Development
Analysis of M&As in the Epifluidic Diagnostics Industry, 2020-2023
Analysis of Government Funding for Epifluidic Diagnostics, 2020-2023
Snapshot of Private Funding for Epifluidic Diagnostics, 2020-2023

Patent Analysis

IP Activity Analysis on Epifluidic Diagnostics (2018-2023)
Sweat-based Epifluidic Diagnostics-Innovation Themes Analysis (2018-2023)
ISF-based Epifluidic Diagnostics-Innovation Themes Analysis (2018-2023)

Growth Opportunity Universe

Growth Opportunity 1: Novel Microfluidic Systems Analyzing Alternate Sampleable Biofluids
Growth Opportunity 2: IoT, AI/ML Algorithms, and Other Advanced Information and Communication Technologies
Growth Opportunity 3: Collaborations between Key Players, Academic Institutes, and Governments